Prime Care Clinical Research Center
Welcome,         Profile    Billing    Logout  
 3 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Azadegan, Reza
NEPTUNUS-Ext, NCT05985915: A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Active, not recruiting
3
613
Europe, Canada, Japan, US, RoW
Ianalumab (VAY736), VAY736, Placebo
Novartis Pharmaceuticals
Sjogrens Syndrome
08/28
07/30
NCT04987294: Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Terminated
2a
19
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
09/22
09/22
Azadegan, Raza
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Azadegan, Reza
NEPTUNUS-Ext, NCT05985915: A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Active, not recruiting
3
613
Europe, Canada, Japan, US, RoW
Ianalumab (VAY736), VAY736, Placebo
Novartis Pharmaceuticals
Sjogrens Syndrome
08/28
07/30
NCT04987294: Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Terminated
2a
19
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
09/22
09/22
Azadegan, Raza
No trials found

Download Options